NCT00816452已完成不适用
Title: Increase Awareness to Osteopenia/Osteoporosis Treatment of Patients With Prostate Cancer, by Bisphosphonate Therapy - Registry.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Sanofi
- 入组人数
- 180
- 试验地点
- 1
- 主要终点
- To evaluate the compliance in male patients with prostate cancer treated with Bisphosphonate and that suffered from Osteopenia/osteoporosis.
研究概览
简要总结
Patients with prostate cancer treated in outpatient clinics will be recruited by their urologist physician.
Primary Objective: To evaluate the compliance in male patients with prostate cancer treated with Bisphosphonate and that suffered from Osteopenia/osteoporosis.
Secondary objectives:
To evaluate the compliance of family physicians to prescribe Bisphosphonate for patients upon recommendation by Urologists.
To evaluate the overall number of patients treated by Bisphosphonate in the out-patient clinics, To evaluate incidence of osteopenia/osteoporosis in this study population.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Man with Prostate Cancer
- •Men ≥70 years old or ≥60 years old treated by LH-RH agonist for at least 2 years or Man who was diagnosed in the past with Osteopenia/osteoporosis
- •Osteopenia/osteoporosis proven by bone density test.
排除标准
- •Creatinine clearance < 30ml/min
- •Hypercalcemia
- •Actual treatment by Bisphosphonate or steroids
- •Hypersensibility to Bisphosphonate or any contraindication to its use.
- •Metastatic prostate Cancer
- •Patients not suitable for compliance.
- •The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
结局指标
主要结局
To evaluate the compliance in male patients with prostate cancer treated with Bisphosphonate and that suffered from Osteopenia/osteoporosis.
时间窗: 6 months
次要结局
- To evaluate the compliance of family physicians to prescribe Bisphosphonate for patients upon recommendation by Urologists.(6 months)
- To evaluate the overall number of patients treated by Bisphosphonate in the out-patient clinics(6 months)
- To evaluate incidence of osteopenia/osteoporosis in this study population.(6 months)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
The safety and efficacy of Irreversible Electroporation for the ablation of prostate cancer assessed by procedural related side effects and post prostatectomy histology: A pilot studyCancer - ProstateProstate cancerACTRN12612000523808Flack Trustees6
终止
2 期
Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone MetastasesProstate CancerBone MetastasesProstate NeoplasmsNCT02582749Ajjai Alva, MD16
进行中（未招募）
不适用
Prostate Cancer BiobankProstatic NeoplasmsNCT04024475Swiss Group for Clinical Cancer Research1,323
已完成
不适用
Patient involvement in prostate cancer treatment decisions.NL-OMON29028300
招募中
不适用
Utrecht Prostate Cohort for Cancer Treatment Intervention Studies and Long-term EvaluationProstate CancerNCT04228211UMC Utrecht1,500